CMS Updates Signature Guidelines
On May 16, 2010, the Centers for Medicare and Medicaid Services (CMS) issued Transmittal 327 which revises the signature requirements for medical review activities of Medicare claim review contractors. Transmittal 327 has an effective date of March 1, 2010 and an implementation date of April 16, 2010, but the changes are effective retroactively to the November 2010 report period for comprehensive error testing. The transmittal updates Chapter 3, Section 3.4.1.1 of the Medicare Program Integrity Manual to require that services provided or ordered for medical review purposes are authenticated by the author. The previous version of this section only required authentication by a legible identifier. Specifically, Transmittal 327 amends Section 3.4.1.1 to:
- Expressly state that stamp signatures are not acceptable. The transmittal clarifies that the method of authentication for services provided or ordered for medical review purposes must be by handwritten or electronic signature.
- Add a new exception for clinical diagnostic tests when a treating physician, who authenticates medical documentation by handwritten or electronic signature, indicates that he or she intended the clinical diagnostic test be performed. The amended section suggests that such medical documentation could be in the form of a progress note.
- Provide that if handwritten signatures are illegible, reviewers should consider evidence in a signature log or attestation statement to determine the identity of the author.
- Finally, when providers fail to meet handwritten signature requirements of Section 3.4.1.1, reviewers should contact providers to inquire as to whether they want to submit an attestation statement or signature log within 20 calendar days.
Interestingly, Transmittal 327 appears to reconcile with similar regulations concerning signatures and authentication of orders, which are contained in the Medicare Conditions of Participation at 42 CFR 482.24(c)(1), by expressly indicating that other regulations and CMS instructions take precedence over signature guidelines set forth in Section 3.4.1.1. Thus, only when the relevant regulations, national or local coverage determinations, and CMS manuals lack specific signature requirements and/or guidelines to determine legibility or presence of signatures for medical review purposes, should Section 3.4.1.1 requirements be followed.
Therefore, based on the new information from CMS in Transmittal 327, acceptable methods for handwritten signatures are:
- a legible full signature;
- a legible first initial and last name
- an illegible signature accompanied by signature log or attestation statement;
- initials over a printed or typed name; and
- initials accompanied by a signature log or attestation statement.
On the other hand, unacceptable signature methods are as follows:
- Rubber stamp signatures, except for clinical diagnostic tests when a treating physician who authenticates medical documentation by handwritten or electronic signature, indicates that he or she intended the clinical diagnostic test be performed;
- illegible signatures with no additional documentation to identify the signature;
- initials with no additional documentation identifying them;
- an unsigned note; and
- a note with the statement “signature on file.”
Smith Haughey Rice & Roegge will continue to monitor developments in this area and distribute updated information as it becomes available.
Summer clerk Charissa Huang contributed to this post.